Small EJ - Search Results

1

Ixabepilone, mitoxantrone, and prednisone for metastatic castration-resistant prostate cancer after docetaxel-based therapy: a phase 2 study of the Department Of Defense Prostate Cancer Clinical Trials Consortium.

Harzstark AL, Rosenberg JE, Weinberg VK, Sharib J, Ryan CJ, Smith DC, Pagliaro LC, Beer TM, Liu G, Small EJ. Harzstark AL, et al. Among authors: small ej. Cancer. 2011 Jun 1;117(11):2419-25. doi: 10.1002/cncr.25810. Epub 2010 Dec 29. Cancer. 2011. PMID: 24048789 Free article. Clinical Trial.

2

Prostate cancer: who to screen, and what the results mean.

Small EJ. Small EJ. Geriatrics. 1993 Dec;48(12):28-30, 35-8. Geriatrics. 1993. PMID: 7504646 Review.

3

A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinoma.

Small EJ, Frye JW, Wilkinson MJ, Carroll PR, Ernest ML, Stagg RJ. Small EJ, et al. Cancer. 1994 Jun 1;73(11):2803-7. doi: 10.1002/1097-0142(19940601)73:11<2803::aid-cncr2820731124>3.0.co;2-6. Cancer. 1994. PMID: 8194022 Clinical Trial.

4

Gallium-avid thymic hyperplasia in an adult after chemotherapy for Hodgkin disease.

Small EJ, Venook AP, Damon LE. Small EJ, et al. Cancer. 1993 Aug 1;72(3):905-8. doi: 10.1002/1097-0142(19930801)72:3<905::aid-cncr2820720340>3.0.co;2-2. Cancer. 1993. PMID: 8334644 Review.

5

A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma.

Wilkinson MJ, Frye JW, Small EJ, Venook AP, Carroll PR, Ernest ML, Stagg RJ. Wilkinson MJ, et al. Among authors: small ej. Cancer. 1993 Jun 1;71(11):3601-4. doi: 10.1002/1097-0142(19930601)71:11<3601::aid-cncr2820711122>3.0.co;2-#. Cancer. 1993. PMID: 8490909 Clinical Trial.

6

The antiandrogen withdrawal syndrome. Experience in a large cohort of unselected patients with advanced prostate cancer.

Small EJ, Srinivas S. Small EJ, et al. Cancer. 1995 Oct 15;76(8):1428-34. doi: 10.1002/1097-0142(19951015)76:8<1428::aid-cncr2820760820>3.0.co;2-t. Cancer. 1995. PMID: 8620419

7

Doxorubicin and dose-escalated cyclophosphamide with granulocyte colony-stimulating factor for the treatment of hormone-resistant prostate cancer.

Small EJ, Srinivas S, Egan B, McMillan A, Rearden TP. Small EJ, et al. J Clin Oncol. 1996 May;14(5):1617-25. doi: 10.1200/JCO.1996.14.5.1617. J Clin Oncol. 1996. PMID: 8622080 Clinical Trial.

8

Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.

Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH. Cher ML, et al. Among authors: small ej. Cancer Res. 1996 Jul 1;56(13):3091-102. Cancer Res. 1996. PMID: 8674067

9

A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium.

Small EJ, Fippin LJ, Ernest ML, Carroll PR. Small EJ, et al. Cancer. 1996 Oct 15;78(8):1775-80. doi: 10.1002/(sici)1097-0142(19961015)78:8<1775::aid-cncr18>3.0.co;2-v. Cancer. 1996. PMID: 8859191 Clinical Trial.

10

Second-line hormonal therapy for advanced prostate cancer: a shifting paradigm.

Small EJ, Vogelzang NJ. Small EJ, et al. J Clin Oncol. 1997 Jan;15(1):382-8. doi: 10.1200/JCO.1997.15.1.382. J Clin Oncol. 1997. PMID: 8996165 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

477 results

Search Page

Filters